A Study of CST-2032 in Subjects With Cognitive Impairment

Clinical trial NCT05033912 · WITHDRAWN

Trial details

NCT number: NCT05033912
Sponsor: CuraSen Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment (MCI)Parkinson Disease (PD)

Start date: 2021-10-01
Primary completion: 2022-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.